Invention Grant
- Patent Title: Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
-
Application No.: US14360137Application Date: 2012-11-21
-
Publication No.: US09624273B2Publication Date: 2017-04-18
- Inventor: Deborah Long , Jessica Flechtner , Mojca Skoberne
- Applicant: Genocea Biosciences, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Genocea Biosciences, Inc.
- Current Assignee: Genocea Biosciences, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Choate, Hall & Stewart, LLP
- Agent Brenda Herschbach Jarrell; Rolando Medina
- International Application: PCT/US2012/066241 WO 20121121
- International Announcement: WO2013/078299 WO 20130530
- Main IPC: C07K14/005
- IPC: C07K14/005 ; C12N7/00 ; A61K39/12 ; A61K39/245 ; A61K39/00
Abstract:
Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. Highly effective vaccines and immunogenic compositions against HSV-2 which can be used therapeutically or prophylactically, are described.
Public/Granted literature
Information query
